Wanli Liu's group reports " PROTAC-Induced BTK Degradation as a Novel Therapy for Mutated BTK C481S Induced Ibrutinib-Resistant B-Cell Malignancies"

Spotlights

Wanli Liu's group reports " PROTAC-Induced BTK Degradation as a Novel Therapy for Mutated BTK C481S Induced Ibrutinib-Resistant B-Cell Malignancies"

Link: https://www.nature.com/articles/s41422-018-0055-1#Sec1

Contact Address: Room D302, Medical Science Building, Tsinghua University, Beijing 100084, China

Tel: (86) 10-62776420 Fax: (86) 10-62776420